Carcinoma, Hepatocellular: all 3,249 studies
Page 3 of 33. Open to participants first (974), then studies with results posted, then the rest; newest registration first within each.
- Ivarmacitinib Combined With Camrelizumab and Apatinib for Unresectable Advanced Hepatocellular Carcinoma With Acquired Resistance to Immune Checkpoint Therapy: A Single-Arm Exploratory Clinical StudyNot yet recruitingNCT07324473Phase 2
- NWRD06 DNA Plasmid for HCC After Curative Resection.RecruitingNCT07324304Phase 2
- DEB-TACE vs cTACE in HCC After TIPSRecruitingNCT07322848Phase 3
- β-alanine in the Treatment of Advanced Hepatocellular CarcinomaRecruitingNCT07317414Phase 2
- An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver CancerRecruitingNCT07315633
- FAD Subtype-Guided Combination Therapy for Unresectable Hepatocellular CarcinomaNot yet recruitingNCT07314372Phase 2
- Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose (RADIANT)RecruitingNCT07312292Phase 2
- Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma HotspotsRecruitingNCT07312162
- A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Hepatocellular Carcinoma Beyond UCSF Criteria Before Liver TransplantationNot yet recruitingNCT07310836
- Phase IIb Study of AST-3424 in Patients With AKR1C3-high Expressing Advanced Hepatocellular CarcinomaRecruitingNCT07310173Phase 2
- A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus First-Line Targeted Immunotherapy in Unresectable Hepatocellular CarcinomaNot yet recruitingNCT07309419Phase 2/3
- The Efficacy of Preoperative Oral Administration of Lactobacillus Reuteri Combined With Preoperative Neoadjuvant/Conversion Immunotherapy in Patients With Primary Resectable Liver CancerNot yet recruitingNCT07306481Not applicable
- Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot StudyRecruitingNCT07305428Not applicable
- Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90RecruitingNCT07303712
- Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver CancerEnrolling by invitationNCT07298577Not applicable
- Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver ResectionRecruitingNCT07295275
- NIR-II Fluorescence-Guided Hepatectomy Using ICG-Cisplatin Nanoprobes for HCCRecruitingNCT07295262Early Phase 1
- Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH)RecruitingNCT07293468Phase 2/3
- A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver CirrhosisRecruitingNCT07291141
- A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)RecruitingNCT07291076Phase 1/2
- Survival Analysis of Surgical Resection Versus Observation in Patients With Initially uHCC Achieving CR After Systemic TherapyEnrolling by invitationNCT07290764
- The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLDRecruitingNCT07285850Phase 2/3
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasRecruitingNCT07285044Phase 2
- A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical PracticeRecruitingNCT07284121
- Multimodal Deep Learning for Postoperative Liver Cancer Risk Stratification and InterventionRecruitingNCT07282184Phase 1/2
- Transarterial Chemoembolization With Low-Dose Bevacizumab Plus Atezolizumab as First-Line Treatment for Unresectable Hepatocellular CarcinomaNot yet recruitingNCT07281664Not applicable
- JMT106 Injection in the Treatment of Advanced Solid TumorsRecruitingNCT07275073Phase 1
- New Diagnostic Criteria in the Evaluation Response to Ablation Treatment of Hepatocellular Carcinoma NodulesRecruitingNCT07272083
- TITAN-HCC: Neoadjuvant and Adjuvant QL1706 With TACE in Resectable Hepatocellular Carcinoma Beyond Milan CriteriaRecruitingNCT07268131Not applicable
- Project for Multi-Omics-Based Early Detection of Hepatocellular Carcinoma (PROMETHEA Study)RecruitingNCT07265271
- TAF Monotherapy Versus ETV Combined With TAF on the Efficacy and Prognosis of Immunotherapy for Hepatitis B-Related Hepatocellular CarcinomaNot yet recruitingNCT07253220Not applicable
- Study of ACC-1898 in Adult Participants With Advanced Solid TumorsNot yet recruitingNCT07252661Phase 1
- A Single-arm Phase II Clinical Study Investigating the Safety and Efficacy of Carbon Ion Radiotherapy in Patients With Hepatocellular Carcinoma Previously Treated With Transarterial Radioembolization (TARE)RecruitingNCT07252323Not applicable
- A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular CarcinomaRecruitingNCT07246668Phase 2
- A Study of DEG6498 in Participants With Solid TumorsRecruitingNCT07244835Phase 1
- Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular CarcinomaRecruitingNCT07243691Not applicable
- A Phase 2 Study of BB102 in Patients With Hepatocellular CarcinomaNot yet recruitingNCT07239986Phase 2
- Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular CarcinamoRecruitingNCT07239245Phase 2
- 15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority TrialNot yet recruitingNCT07237204Not applicable
- Deep Learning-Based Multidimensional Body Composition Mapping for Outcome Prediction in HCC Patients Undergoing TACERecruitingNCT07235410
- Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.RecruitingNCT07227012Phase 1/2
- Computer Guided Microwave Liver AblationRecruitingNCT07226869Not applicable
- Maintenance Zanzalintinib and Durvalumab in Participants With Advanced Hepatocellular CancerNot yet recruitingNCT07226063Phase 2
- A Noninvasive and Screening miRNA Signature for Gastrointestinal CancerRecruitingNCT07224750
- Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid TumorsNot yet recruitingNCT07224568Phase 1
- Patient Preference for Subcutaneous vs. Intravenous Immune TherapyRecruitingNCT07223424Phase 2
- Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 FailureRecruitingNCT07219459Phase 2
- GKL-006 Injection Plus TACE Versus TACE Alone in Patients With Unresectable Hepatocellular CarcinomaRecruitingNCT07209813Phase 2
- Conversion Therapy Using TACE/HAIC With Anti-Angiogenic and Immunotherapy for Initially Unresectable Hepatocellular Carcinoma Achieving Complete Response or Resectability, Followed by Surgery or Continued Systemic Treatment: A Prospective Cohort StudyNot yet recruitingNCT07206511
- A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid MalignanciesRecruitingNCT07197554Phase 1
- Adebrelimab + Apatinib in Advanced HCC Post-Systemic TherapyNot yet recruitingNCT07192848Phase 2
- International Study on Treatment of Liver (HCC) Patients With IRENot yet recruitingNCT07192731Not applicable
- Systemic Chemotherapy With FOLFOX Plus Atezolizumab & Bevacizumab for Patients With Advanced HCC Who Previously Received Atezolizumab & BevacizumabRecruitingNCT07192185Phase 2
- International Study on Treatment of Patients With Metastatic Colorectal Liver Lesions Patients With IRENot yet recruitingNCT07191548Not applicable
- EDN Combined With TACE/HAIC and Second-Line Immune-Targeted Treatment Versus TACE/HAIC Alone in Locally Advanced HCC With Portal Vein Tumor Thrombosis After First-Line Therapy Failure: A Prospective, Multicenter, Randomized Controlled TrialNot yet recruitingNCT07187284Phase 1/2
- Adjuvant Radiotherapy of Sintilimab Versus TACE for HCCRecruitingNCT07186621Phase 3
- Immunogenomic Dynamics and Biomarkers in Patients With Hepatocellular Carcinoma Receiving ImmunotherapyRecruitingNCT07186010
- Liver Diseases: Extracellular Vesicles as BiomarkersNot yet recruitingNCT07185360Not applicable
- CT Volume Measurement of Hepatocellular CarcinomaNot yet recruitingNCT07183566
- The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib：A Prospective, Single-arm, Multicenter, Observational StudyNot yet recruitingNCT07180459
- Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular CarcinomaRecruitingNCT07179900Phase 2
- Evaluating the roLe of Multiplexed PET Imaging in the Detection and Staging of hepatocellulaR Carcinoma and gAstro-entero-pancreatic TumorsRecruitingNCT07178587Not applicable
- Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular CarcinomaRecruitingNCT07176650Phase 1
- Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver CancerRecruitingNCT07174570Phase 2
- Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular InvasionRecruitingNCT07170345
- Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT TrialRecruitingNCT07166406Phase 3
- A Study of ZW251 in Participants With Advanced Solid TumorsRecruitingNCT07164313Phase 1
- Exploration of Postoperative Adjuvant Therapy for HCC Patients With Positive TBNot yet recruitingNCT07160361Phase 4
- The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver TumorsRecruitingNCT07159048Not applicable
- ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCCRecruitingNCT07157969Phase 2
- Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular CarcinomaNot yet recruitingNCT07157306Phase 2
- A Study on the Heterogeneity of Efficacy of Interventional Therapy Combined With Systemic Therapy for Liver Cancer Based on Multi-center Real-world DataNot yet recruitingNCT07156617
- Apatinib Mesylate and Camrelizumab Combined With TACE as Neoadjuvant Therapy for Hepatocellular CarcinomaRecruitingNCT07154082Phase 2
- Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination TherapyNot yet recruitingNCT07151326Phase 2
- The Treatment of Liver Injury After Liver Resection With Polyene PhosphatidylcholineRecruitingNCT07150624Phase 4
- A Phase II Single-Arm Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Lenvatinib and TACE for Advanced Hepatocellular CarcinomaNot yet recruitingNCT07150377Phase 2
- Hepatocellular Carcinoma Identification Using Delta-HLDRecruitingNCT07148310
- Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T CellsRecruitingNCT07148050Phase 1
- Y-90 Treatment Response Using Transarterial RadioembolizationRecruitingNCT07145801Phase 2
- Evaluation Of Liver Resection Using Harmonic Scalpel Versus Cavitron Ultrasonic Surgical Aspirator (CUSA).Not yet recruitingNCT07142876Not applicable
- The Impact of Emotional Stress on Immunotherapy Outcomes in Liver Cancer Patients: A Multi-Cohort StudyRecruitingNCT07141056
- Efficacy & Safety of Anticoagulants in Cirrhosis ± HCCRecruitingNCT07132515Phase 4
- A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular CarcinomaNot yet recruitingNCT07131501Phase 2
- Role of Long Noncoding RNA LINC01134 in Metastasis of Hepatitis C Virus-related Hepatocellular CarcinomaNot yet recruitingNCT07130474
- A Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization (TACE) Combined With Iparomlimab and Tuvonralimab Injection and Bevacizumab Injection for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma (HCC)Not yet recruitingNCT07128251Phase 2
- Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein ThrombosisRecruitingNCT07122089Phase 2
- Post-Radical Treatment Antiviral Strategies in HBV-Related Liver Cancer: Impact on Tumor PrognosisNot yet recruitingNCT07120750
- ProspEXPO : Study of the Associations Between Hepatocellular Carcinoma and Chemical and Psychosocial Environmental EXPOsomeRecruitingNCT07119957Not applicable
- AHCC® as Immune Modulator in Cancer Patients Treated With ImmunotherapyNot yet recruitingNCT07118735Not applicable
- A Prospective Observational Cohort Study on Dynamic CD8+ T-cell Profiling and Multi-omics Biomarkers for Predicting Conversion Therapy Response in Unresectable Hepatocellular CarcinomaNot yet recruitingNCT07117279
- A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular CarcinomaRecruitingNCT07116486Phase 1
- A Single-center, Single-arm, Phase II Clinical Study of Iparomlimab and Tuvonralimab Injection Combined With Regorafenib in the Treatment of Advanced Second-line or Above Hepatocellular CarcinomaNot yet recruitingNCT07115550Not applicable
- Restoring Bile Acid Homeostasis Via Lifestyle Adjustments to Prevent the Development of Liver CancerNot yet recruitingNCT07111130Not applicable
- Yttrium-90 Radiation Segmentectomy for Hepatocellular CarcinomaNot yet recruitingNCT07110233Not applicable
- A Study of GV20-0251 in Advanced or Refractory Solid TumorsRecruitingNCT07106827Phase 1
- An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer.RecruitingNCT07101237
- TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune MicroenvironmentRecruitingNCT07100405
- Tauroursodeoxycholic Acid (TUDCA) Plus Camrelizumab and Regorafenib in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and BevacizumabRecruitingNCT07100392Phase 2
- 29-Gene Liver Cancer Subtype and Immunotherapy EffectivenessNot yet recruitingNCT07100236
- Predictors of HCC in Post-HCV Cirrhotic Patients After SVRNot yet recruitingNCT07097870